How to order Keflex (cephalexin) for a patient with paronychia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order Keflex (Cephalexin) for Paronychia

For acute paronychia with signs of bacterial infection, prescribe cephalexin 500 mg orally every 6 hours (or 250 mg every 6 hours for milder cases) for 7-10 days, targeting the most common gram-positive pathogens including Staphylococcus aureus and Streptococcus species. 1, 2

Dosing Specifications

Adult Dosing

  • Standard dose: 250 mg orally every 6 hours for mild to moderate skin and soft tissue infections 2
  • Higher dose: 500 mg orally every 6 hours for more severe infections or less susceptible organisms 2
  • Alternative regimen: 500 mg every 12 hours may be used for uncomplicated skin and skin structure infections 2
  • Maximum daily dose: Do not exceed 4 grams per day; if higher doses are required, consider parenteral cephalosporins 2

Pediatric Dosing

  • Standard dose: 25-50 mg/kg/day divided into doses every 6 hours 2
  • For skin infections: Total daily dose may be divided and given every 12 hours in children over 1 year 2
  • Severe infections: Double the standard dosage 2

When to Prescribe Oral Antibiotics

Indications for cephalexin in paronychia:

  • Presence of purulent drainage or abscess after adequate drainage has been performed 3, 4
  • Signs of spreading infection including erythema, warmth, or edema extending beyond the nail fold 1
  • Moderate to severe infection (Grade 2-3) with systemic signs 1
  • Immunocompromised patients even with mild infection 5
  • Failed conservative management with topical therapy after 2 weeks 3, 4

Important caveat: Oral antibiotics are usually not needed if adequate drainage is achieved, unless the patient is immunocompromised or severe infection is present 4, 5

Microbiological Considerations

Cephalexin provides excellent coverage for the most common pathogens in paronychia:

  • Gram-positive bacteria (72% of isolates): Including Staphylococcus aureus and Streptococcus species 6
  • Some gram-negative bacteria (23% of isolates) 6
  • Achieves urinary concentrations of 500-1000 mcg/mL, far exceeding MIC for common pathogens 7

Critical limitation: Up to 25% of paronychia cases have secondary bacterial or fungal superinfections 1, 3, 4

When Cephalexin May Fail

If initial treatment with cephalexin fails after 2 weeks, switch to sulfamethoxazole-trimethoprim (Bactrim) as it provides broader coverage including MRSA. 3, 4

Alternative considerations if cephalexin is ineffective:

  • For MRSA coverage: Consider trimethoprim-sulfamethoxazole, doxycycline, or clindamycin 1
  • Avoid clindamycin as first-line due to inadequate coverage for some streptococcal species and increasing resistance 4
  • For broader coverage: Amoxicillin-clavulanate 500/125 mg every 12 hours covers both typical pathogens and beta-lactamase producers 4

Prescription Writing Details

Sample prescription:

  • Drug: Cephalexin 500 mg capsules
  • Quantity: #56 capsules (for 7 days) or #80 capsules (for 10 days)
  • Directions: Take one capsule by mouth every 6 hours for 7-10 days
  • Refills: None 2

For liquid suspension (pediatric):

  • Prepare suspension at time of dispensing by adding appropriate amount of water 2
  • Store in refrigerator after mixing 2
  • May be kept for 14 days without significant loss of potency 2

Adjunctive Measures to Prescribe Concurrently

Always combine oral antibiotics with:

  • Warm water or white vinegar soaks (1:1 dilution) for 15 minutes 3-4 times daily 4, 5
  • Topical 2% povidone-iodine twice daily 1, 3, 4
  • Mid to high potency topical corticosteroid ointment to nail folds twice daily 3, 4

Duration and Follow-up

  • Treatment duration: 7-10 days for skin and soft tissue infections 1, 2
  • Reassessment: Evaluate response after 2 weeks 1, 3, 4
  • Escalation: If no improvement after 2 weeks, obtain cultures and consider referral to dermatology or podiatry 3, 4

Special Populations

Renal impairment: Patients with creatinine clearance <30 mL/min require dose reduction proportional to reduced renal function 7

Allergy considerations: Cephalexin has a low incidence of allergy due to its stability and chemical configuration, but cross-reactivity with penicillin allergy occurs in approximately 10% of patients 7

Common Pitfalls to Avoid

  • Do not prescribe oral antibiotics without ensuring adequate drainage if an abscess is present 4, 5
  • Do not obtain cultures routinely for simple paronychia, but do obtain them in severe cases, treatment failures, or immunocompromised patients 1, 4
  • Do not forget to address underlying causes such as ingrown toenail, which may require specific management beyond antibiotics 3
  • Do not use cephalexin alone for chronic paronychia, which is primarily an irritant dermatitis requiring topical corticosteroids rather than antibiotics 8, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Paronychia of the Toenail

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Paronychia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute and Chronic Paronychia.

American family physician, 2017

Research

Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2010

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Guideline

Treatment of Chronic Paronychia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.